石四药集团：已取得中国国家药品监督管理局有关吲哚布芬片(0.2g)的药品生产注册批件

Core Viewpoint - The company has obtained the production registration approval for Indobufene Tablets (0.2g) from the National Medical Products Administration of China, which is classified as a Class 3 chemical drug and is considered to have passed the consistency evaluation [1] Group 1: Product Information - Indobufene Tablets are primarily used for the treatment of ischemic cardiovascular diseases caused by arteriosclerosis, ischemic cerebrovascular diseases, and venous thrombosis [1] - The drug can also be used to prevent thrombosis during hemodialysis [1]